(DC): Lemon Ginger Lozenges | 500mg THC I 10ct

THC

THC: 1.82%

Lemon Ginger Lozenges – Edible | 500mg THC | 10ct (50mg each)

Lineage: Infused with premium cannabis oil, crafted for high-potency, fast-onset effects

Flavor Profile: Zesty lemon with a spicy ginger kick for a refreshing balance

Aroma: Bright citrus with subtle herbal spice

Soothe. Energize. Elevate.

The Lemon Ginger Lozenges are a potent and flavorful edible designed for fast absorption and consistent results. Each lozenge contains 50mg THC, with a total of 500mg THC per 10-piece pack, offering high-dosage relief in a discreet, easy-to-use form.

Formulated for sublingual absorption, these lozenges allow cannabinoids to enter the bloodstream quickly through mucosal membranes, resulting in a faster onset compared to traditional edibles. The crisp lemon flavor combined with spicy ginger makes them as enjoyable as they are effective.

Ideal for:

✔️ Fast-acting THC relief

✔️ Managing chronic pain and stress

✔️ Boosting mood and relaxation

✔️ Discreet, portable dosing

✔️ Experienced consumers seeking higher potency

Available now at:

🛒 High Demand Dispensary

📍 511 11th Street SE, Washington, DC

Pick up your Lemon Ginger Lozenges (500mg THC, 10ct) today and enjoy powerful, flavorful relief with every piece.

Cannabinoids

Cannabinoids are naturally occurring chemical compounds that are found in cannabis and provide consumers with a wide range of effects. THC and CBD are examples of some of the most commonly known cannabinoids.

D9-THC

18.00mg/g

About the Brand

We grow weed for THE people.

All the people.

Happy people.

Stressed people.

People looking for a little pain relief.

And for those who just need a lift after a long day.

Because while all people are created equal,

All cannabis is not.

So, here’s our party line-

Give the people

the highest quality weed

that’s safe to smoke,

stacked with terps,

and make it accessible to everyone.

Because what’s the point of growing the world's best weed?

If people can’t smoke it.

Weed the People.